UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.08 +0.08 (+0.10%) GOLD FUTURES
2,311.40 +0.40 (+0.02%) DOW
38,163.56 +260.27 (+0.69%) Bitcoin GBP
47,139.38 +1,472.38 (+3.22%)
Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:47PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.48B |
| Enterprise value | 2.11B |
| Trailing P/E | 25.40 |
| Forward P/E | 153.85 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.53 |
| Price/book (mrq) | 4.89 |
| Enterprise value/revenue | 4.38 |
| Enterprise value/EBITDA | 19.26 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -0.50% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 34.28 |
| 52-week low 3 | 20.84 |
| 50-day moving average 3 | 23.82 |
| 200-day moving average 3 | 26.58 |
Share statistics
| Avg vol (3-month) 3 | 1.08M |
| Avg vol (10-day) 3 | 1.49M |
| Shares outstanding 5 | 103.84M |
| Implied shares outstanding 6 | 103.84M |
| Float 8 | 85.31M |
| % held by insiders 1 | 11.41% |
| % held by institutions 1 | 85.09% |
| Shares short (15 Apr 2024) 4 | 21.12M |
| Short ratio (15 Apr 2024) 4 | 24.85 |
| Short % of float (15 Apr 2024) 4 | 28.67% |
| Short % of shares outstanding (15 Apr 2024) 4 | 20.34% |
| Shares short (prior month 15 Mar 2024) 4 | 20.22M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 22.54% |
| Operating margin (ttm) | 20.09% |
Management effectiveness
| Return on assets (ttm) | 11.96% |
| Return on equity (ttm) | 21.91% |
Income statement
| Revenue (ttm) | 523.53M |
| Revenue per share (ttm) | 5.12 |
| Quarterly revenue growth (yoy) | 39.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 122.8M |
| Net income avi to common (ttm) | 117.2M |
| Diluted EPS (ttm) | 0.94 |
| Quarterly earnings growth (yoy) | 74.80% |
Balance sheet
| Total cash (mrq) | 410.76M |
| Total cash per share (mrq) | 3.94 |
| Total debt (mrq) | 76k |
| Total debt/equity (mrq) | 0.01% |
| Current ratio (mrq) | 5.18 |
| Book value per share (mrq) | 5.26 |
Cash flow statement
| Operating cash flow (ttm) | 124.84M |
| Levered free cash flow (ttm) | 121.75M |
© 2024 Yahoo. All rights reserved.